Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Verkada Accelerates Physical AI with NVIDIA
Verkada is Scaling Its Physical AI Platform Across More than 2.4 Million Devices Globally with a New Technical Collaboration and Investment from NVIDIA
Verkada, a leader in AI-powered physical security and operations, today announced a collaboration with NVIDIA to accelerate the development and deployment of physical AI across the built environment. NVIDIA also joins as a new investor in Verkada, following a strategic investment from Alphabet’s CapitalG at the end of last year.
Verkada is applying AI to transform how schools, hospitals, retailers, manufacturers, and other organizations turn real-world operational data into actionable intelligence — helping keep people and places safe.
“Verkada has been building and deploying Physical AI before the term existed. With our footprint of more than 2.4 million devices across 170 countries and 30,000 organizations, we’ve proven that the built environment is one of the largest beneficiaries of AI,” said Filip Kaliszan, Co-Founder and CEO at Verkada. “Working with NVIDIA supercharges what we’ve spent nearly a decade building: AI that keeps students safe in schools, protects workers on factory floors, helps retailers prevent theft, and enables organizations to operate more efficiently.”
Verkada is strengthening the models and data flywheel underpinning its intelligent video analytics through its collaboration with NVIDIA, advancing AI-powered video search, multimodal embeddings and vector retrieval for next-generation semantic search, and synthetic data generation to augment training datasets and improve accuracy.
By leveraging NVIDIA Cosmos world foundation models and NVIDIA Physical AI Data Factory, Verkada has accelerated model training and inference across its rapidly expanding global footprint on NVIDIA accelerated computing. Since the collaboration began, Verkada has improved the mean average precision (mAP) of its AI-powered search by 68% for spatial-temporal understanding, delivering faster, more accurate, and more robust search capabilities…
Full release here, originally announced July 1st, 2026.
XRHealth Acquires Swing Therapeutics, Expanding Its Platform to Mobile Digital Therapeutics
Acquisition Extends Digital Health Care from Augmented and Virtual Reality Glasses to Smartphone Apps, Smartwatches, and IoT Devices, Combining AI and Licensed Clinicians to Deliver Continuous, Reimbursable Care for Chronic Conditions
XRHealth, the leading platform for therapeutic technologies, today announced
The acquisition adds Swing Therapeutics’ FDA De Novo–authorized Stanza program to XRHealth’s existing behavioral health and chronic pain capabilities, deepening the platform’s reach into two of the most undertreated conditions in the country: fibromyalgia and chronic pain.
“When we founded Swing, we believed that the future of chronic pain care had to look fundamentally different: more accessible, more personalized, and grounded in evidence,” says Mike Rosenbluth, Founder and CEO at Swing Therapeutics. “Joining XRHealt
Swing Therapeutics’ Stanza is the first digital behavioral therapy indicated for treatment of the symptoms of fibromyalgia, a widespread chronic pain condition impacting 10 million people in the United States. In a Phase 3 randomized controlled trial published in The Lancet, Stanza demonstrated
The acquisition also brings Swing Care, Swing Therapeutics’ virtual specialty care platform for fibromyalgia and chronic pain, into the XRHealth ecosystem. Developed in collaboration with leading fibromyalgia clinicians, including Medical Director Dr. Andrea Chadwick, a globally recognized expert in the field, Swing Care delivers comprehensive, multidisciplinary care that combines the Stanza digital therapeutic with medication management, mental health support, and personalized coaching.
“The future of therapeutic care is technology. Not as a supplement to medicine, but as the medicine itself—delivered through AI, monitored by licensed clinicians, reimbursed by insurance, and continuously improved by outcomes data,” says Eran Orr, CEO at XRHealth…
Full release here, originally announced July 15th, 2026.
No comments:
Post a Comment